Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-006441

CHIEF FINANCIAL OFFICER gave up 791 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 2,695 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-10 Option exercise +2,695 12,506 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-10 Shares withheld for taxes −791 $10.71 $8,472 11,715 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-10 Option exercise · Restricted Share Unit +2,695 8,082 D
Loading xslF345X04/form4-04112023_090443.xml…